This page collects WhisperX intelligence signals tagged #HIV. It is designed for humans, search engines, and AI agents: each item links to a canonical source-backed record with sector, source, timestamp, credibility, and exportable structured data.
Three decades after the landmark settlement of Japan's HIV-tainted blood scandal, the core issues of prejudice and discrimination against people with infectious diseases persist, according to the plaintiffs who led the fight. Tomomi Goto, 53, who currently heads the plaintiffs' group in Tokyo, delivers a stark warning ...
A new analysis reveals Merck's experimental HIV prevention pill, MK 8527, could be mass-produced for less than $5 per patient annually. This strikingly low potential cost is fueling pressure on the pharmaceutical giant to license the drug for broad access in low- and middle-income countries, where the HIV burden is hig...